title: Levetiracetam in L-dopa-induced dyskinesia.
authors.forename: G
authors.initials: G
authors.lastname: Meco
authors.forename: E
authors.initials: E
authors.lastname: Fabrizio
authors.forename: A
authors.initials: A
authors.lastname: Epifanio
authors.forename: G
authors.initials: G
authors.lastname: Di Raimondo
authors.forename: N
authors.initials: N
authors.lastname: Vanacore
authors.forename: L
authors.initials: L
authors.lastname: Morgante
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000009:adverse effects; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D000978:Antiparkinson Agents; D000077287:Levetiracetam; D007980:Levodopa; D010889:Piracetam